Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Investigative Ophthalmology and Visual Science

• Publication date

  2008-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1167/iovs.07-1194PMID 18326747
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interaction between bevacizumab and murine VEGF-A: a reassessment.

  2008cited by this paper
• Targeting VEGF-A to treat cancer and age-related macular degeneration.

  2007cited by this paper
• Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization.

  2006cited by this paper
• Cross-species Vascular Endothelial Growth Factor (VEGF)-blocking Antibodies Completely Inhibit the Growth of Human Tumor Xenografts and Measure the Contribution of Stromal VEGF*

  2006cited by this paper
• A novel imaging technique for experimental choroidal neovascularization.

  2006cited by this paper
• Photodynamic Therapy of Experimental Choroidal Neovascularization in the Mouse

  2006cited by this paper
• The price of sight--ranibizumab, bevacizumab, and the treatment of macular degeneration.

  2006cited by this paper
• Ranibizumab for neovascular age-related macular degeneration.

  2006cited by this paper
• VEGF INHIBITION STUDY IN OCULAR NEOVASCULARIZATION CLINICAL TRIAL GROUP. PEGAPTANIB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

  2004cited by this paper
• Choroidal neovascularization.

  2004cited by this paper
• Pegaptanib for neovascular age-related macular degeneration.

  2004cited by this paper
• High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.

  2004cited by this paper
• Targeted disruption of the CD18 or ICAM-1 gene inhibits choroidal neovascularization.

  2003cited by this paper
• Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration

  2003cited by this paper
• Investigation of laser-induced choroidal neovascularization in the rat.

  2003cited by this paper
• VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier.

  2003cited by this paper
• Macrophage depletion inhibits experimental choroidal neovascularization.

  2003cited by this paper
• VEGF‐TRAPR1R2 suppresses choroidal neovascularization and VEGF‐induced breakdown of the blood–retinal barrier

  2003cited by this paper
• Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

  2002cited by this paper
• Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization.

  2001cited by this paper
• Quantitative image analysis of laser-induced choroidal neovascularization in rat.

  2000cited by this paper
• VEGF is major stimulator in model of choroidal neovascularization.

  2000cited by this paper
• Lectin Intravital Perfusion Studies in Tumor-bearing Mice: Micrometer-resolution, Wide-area Mapping of Microvascular Labeling, Distinguishing Efficiently and Inefficiently Perfused Microregions in the Tumor

  1998cited by this paper
• Applications of Lectins and Neoglycoconjugates in Histology and Pathology

  1998cited by this paper
• Expression of vascular endothelial growth factor in experimental choroidal neovascularization

  1997cited by this paper
• Vascular endothelial growth factor expression in choroidal neovascularization in rats

  1997cited by this paper
• Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor.

  1996cited by this paper
• Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes.

  1996cited by this paper
• Levels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularisation.

  1996cited by this paper
• Microscopic visualization of the retina by angiography with high-molecular-weight fluorescein-labeled dextrans in the mouse.

  1993cited by this paper
• The development of an experimental model of subretinal neovascularization in disciform macular degeneration.

  1979cited by this paper

• Antibody blockade of Jagged1 attenuates choroidal neovascularization

  2023cites this paper
• Homeostasis and dyshomeostasis of the retina

  2023cites this paper
• Regulatable Complement Inhibition of the Alternative Pathway Mitigates Wet Age-Related Macular Degeneration Pathology in a Mouse Model

  2023cites this paper
• Biology and therapeutic targeting of vascular endothelial growth factor A

  2023cites this paper
• Evaluation of a connexin-based peptide for the treatment of age-related macular degeneration

  2022cites this paper
• Evaluation of sex differences in laser-induced choroidal neovascularization severity, phenotype and disease progression

  2022cites this paper
• Licochalcone A alleviates laser-induced choroidal neovascularization by inhibiting the endothelial-mesenchymal transition via PI3K/AKT signaling pathway.

  2022cites this paper
• [Prospects and Challenges of Anti-VEGF Drug Treatment for Pathological Angiogenesis of the Retina].

  2021cites this paper
• Heparin-binding VEGFR1 variants as long-acting VEGF inhibitors for treatment of intraocular neovascular disorders

  2021cites this paper
• Natural immunoglobulin M-based delivery of a complement alternative pathway inhibitor in mouse models of retinal degeneration.

  2021cites this paper
• Subretinal Rather Than Intravitreal Adeno-Associated Virus–Mediated Delivery of a Complement Alternative Pathway Inhibitor Is Effective in a Mouse Model of RPE Damage

  2021cites this paper
• Immunological aspects of RPE cell transplantation.

  2021cites this paper
• Investigation of circRNA Expression Profiles and Analysis of circRNA-miRNA-mRNA Networks in an Animal (Mouse) Model of Age-Related Macular Degeneration

  2020cites this paper
• Models of Pathologies Associated with Age-Related Macular Degeneration and Their Utilities in Drug Discovery

  2020cites this paper
• Photothermal Optical Coherence Tomography of Anti-Angiogenic Treatment in the Mouse Retina Using Gold Nanorods as Contrast Agents

  2019cites this paper
• Visualization of Mouse Choroidal and Retinal Vasculature Using Fluorescent Tomato Lectin Perfusion

  2019cites this paper
• Contrast-Enhanced Optical Coherence Tomography Using Gold Nanorods By

  2019cites this paper
• Anti-Angiogenic and Anti-Scarring Dual Action of an Anti-Fibroblast Growth Factor 2 Aptamer in Animal Models of Retinal Disease

  2019cites this paper
• Inhibition of the alternative complement pathway accelerates repair processes in the murine model of choroidal neovascularization.

  2019cites this paper
• Indocyanine green molecular angiography of choroidal neovascularization

  2019cites this paper
• Flt3 Regulation in the Mononuclear Phagocyte System Promotes Ocular Neovascularization

  2018cites this paper
• AAV2/8 Anti-angiogenic Gene Therapy Using Single-Chain Antibodies Inhibits Murine Choroidal Neovascularization

  2018cites this paper
• High‐density lipoprotein mutant eye drops for the treatment of posterior eye diseases

  2017cites this paper
• A SEMA3E mutant resistant to cleavage by furins (UNCL-SEMA3E) inhibits choroidal neovascularization.

  2016cites this paper
• A Sema3C Mutant Resistant to Cleavage by Furin (FR-Sema3C) Inhibits Choroidal Neovascularization

  2016cites this paper
• Increased VEGF‐A promotes multiple distinct aging diseases of the eye through shared pathomechanisms

  2016cites this paper
• Fracción activa del factor derivado del epitelio pigmentario (PEDF) en el tratamiento de la neovascularización coroidea en modelo animal de degeneración macular asociada a la edad

  2016cites this paper
• Mechanistic and therapeutic evaluation of a novel antiantiogenic small molecule

  2016cites this paper
• Targeting the tight junction protein, zonula occludens-1, with the connexin43 mimetic peptide, αCT1, reduces VEGF-dependent RPE pathophysiology

  2016cites this paper
• Targeting Platelet-Derived Growth Factor Receptor β(+) Scaffold Formation Inhibits Choroidal Neovascularization.

  2016cites this paper
• ANGPTL4–αvβ3 interaction counteracts hypoxia‐induced vascular permeability by modulating Src signalling downstream of vascular endothelial growth factor receptor 2

  2016cites this paper
• A Quantitative and Standardized Method for the Evaluation of Choroidal Neovascularization Using MICRON III Fluorescein Angiograms in Rats

  2015cites this paper
• Phosphatidylserine (PS) Is Exposed in Choroidal Neovascular Endothelium: PS-Targeting Antibodies Inhibit Choroidal Angiogenesis In Vivo and Ex Vivo.

  2015cites this paper
• Gene Therapies for Neovascular Age-Related Macular Degeneration.

  2015cites this paper
• A Simple Optical Coherence Tomography Quantification Method for Choroidal Neovascularization

  2015cites this paper
• Effect of chromogranin A‐derived vasostatin‐1 on laser‐induced choroidal neovascularization in the mouse

  2015influential citation
• Local production of the alternative pathway component factor B is sufficient to promote laser-induced choroidal neovascularization.

  2015cites this paper
• Retina Phosphatidylserine ( PS ) Is Exposed in Choroidal Neovascular Endothelium : PS-Targeting Antibodies Inhibit Choroidal Angiogenesis In Vivo and Ex Vivo

  2015cites this paper
• Rôle des acides gras polyinsaturés alimentaires dans l'homéostasie lipidique de la rétine en conditions physiologiques et pathologiques liées au vieillissement

  2014cites this paper
• [Review and expert opinion in age related macular degeneration. Focus on the pathophysiology, angiogenesis and pharmacological and clinical data].

  2014cites this paper
• Mechanisms of age‐related macular degeneration and therapeutic opportunities

  2014cites this paper
• VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2

  2014cites this paper
• Age-Related Macular Degeneration: Classification and Pathogenesis

  2014cites this paper
• Expertises croisées dans la dégénérescence maculaire liée à l’âge. Focus sur la physiopathologie, l’angiogenèse, les données pharmacologiques et cliniques

  2014cites this paper
• VEGF Receptor Blockade Markedly Reduces Retinal Microglia/Macrophage Infiltration into Laser-Induced CNV

  2013cites this paper
• Cancer Therapy : Preclinical Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL 12

  2013cites this paper
• An angiotensin-converting enzyme inhibitor modulates stromal-derived factor-1 through CD26/dipeptidyl peptidase IV to inhibit laser-induced choroidal neovascularization

  2013cites this paper
• Oxidative Stress Sensitizes Retinal Pigmented Epithelial (RPE) Cells to Complement-mediated Injury in a Natural Antibody-, Lectin Pathway-, and Phospholipid Epitope-dependent Manner*

  2013cites this paper
• Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12

  2013cites this paper
• In-vivo investigation of laser-induced choroidal neovascularization in rat using spectral-domain optical coherence tomography (SD-OCT)

  2013cites this paper
• Aurintricarboxylic acid inhibits complement activation, membrane attack complex, and choroidal neovascularization in a model of macular degeneration.

  2013influential citation
• An Angiogenic Role for Adrenomedullin in Choroidal Neovascularization

  2012cites this paper
• IL‐27 inhibits pathophysiological intraocular neovascularization due to laser burn

  2012cites this paper
• Animal models of age related macular degeneration.

  2012cites this paper
• Systemic Human CR2-Targeted Complement Alternative Pathway Inhibitor Ameliorates Mouse Laser-Induced Choroidal Neovascularization

  2012cites this paper
• Concordance of preclinical and clinical pharmacology and toxicology of monoclonal antibodies and fusion proteins: soluble targets

  2012cites this paper
• Regulation of angiogenesis and choroidal neovascularization by members of microRNA-23∼27∼24 clusters

  2011cites this paper
• The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization.

  2011cites this paper
• Druggable Targets and Therapeutic Agents for Disorders of the Back of the Eye

  2011cites this paper
• Effects of Docosahexaenoic Acid in Preventing Experimental Choroidal Neovascularization in Rodents.

  2011cites this paper
• Hypoxia-regulated retinal glial cell-specific promoter for potential gene therapy in disease.

  2011cites this paper
• Rac1 activates HIF-1 in laser induced choroidal neovascularization.

  2011cites this paper
• Annexin A2 Promotes Glioma Cell Invasion and Tumor Progression

  2011cites this paper
• Suppression and Regression of Choroidal Neovascularization in Mice by a Novel CCR2 Antagonist, INCB3344

  2011cites this paper
• Improved assessment of laser-induced choroidal neovascularization.

  2010cites this paper
• Optimization of laser-induced choroidal neovascularization in African green monkeys.

  2010cites this paper
• A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration.

  2010cites this paper
• Neuroprotectin D1 Attenuates Laser-induced Choroidal Neovascularization in Mouse

  2010cites this paper
• Inhibitory efficacy of hypoxia-inducible factor 1α short hairpin RNA plasmid DNA-loaded poly (D, L-lactide-co-glycolide) nanoparticles on choroidal neovascularization in a laser-induced rat model

  2010cites this paper
• Review of the Ocular Angiogenesis Animal Models

  2009cites this paper
• A peptide derived from type 1 thrombospondin repeat-containing protein WISP-1 inhibits corneal and choroidal neovascularization.

  2009cites this paper
• Chapter 6. Mouse models to investigate anti-cancer effects of VEGF inhibitors.

  2008cites this paper
• Chapter 6. Ocular models of angiogenesis.

  2008cites this paper
• Interaction between bevacizumab and murine VEGF-A: a reassessment.

  2008cites this paper